Literature DB >> 6999408

[Detection of methotrexate in human serum. Comparison between an enzymatic and an enzyme-immunologic method].

A Schalhorn, W Wilmanns.   

Abstract

High-dose methotrexate therapy with following citrovorum factor rescue necessitates the regular determinations of methotrexate (MTX) serum concentrations. A simple enzymatic assay by MTX induced inhibition of dihydrofolate reductase is described. The results gained with this assay are compared with those of a new enzyme immunoassay (MTX-EMIT). Between 5 X 10(-7) M and 1 X 10(-3) M the results of both tests are nearly the same, and the coefficient of correlation is 0,9980. At MTX concentrations below 5 X 10(-7) M the results of the MTX-EMIT lie nearly always higher than and differ considerably from those of the enzymatic method; the coefficient of correlation is only 0.7007. If it is possible to enhance the sensitivity of the MTX-EMIT, this test enables the very quick and easy determination of MTX serum concentrations in the whole range of clinical importance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999408     DOI: 10.1159/000214791

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  5 in total

1.  Ferrokinetics after high-dose methotrexate therapy.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Klin Wochenschr       Date:  1981-10-01

2.  Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Klin Wochenschr       Date:  1983-11-02

3.  [Adjuvant chemotherapy of malignant bone tumors].

Authors:  W Wilmanns; H Sauer; A Schalhorn
Journal:  Langenbecks Arch Chir       Date:  1982

4.  The influence of high-dose methotrexate therapy on serum iron.

Authors:  A Schalhorn; W Wilmanns; G E Koczorek
Journal:  Klin Wochenschr       Date:  1986-05-15

5.  Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate.

Authors:  A Schalhorn; H Sauer; W Wilmanns; G Stupp-Poutot
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.